$BNTX news
The latest BNTX stock news: headlines, filings, AI summaries and sentiment for $BNTX, updated around the clock.
- BioNTech Acquires Rare Pediatric Disease Priority Review Voucher from Scholar Rock for $205 Million
- BioNTech Reports Q3 2026 Earnings with Profit Turnaround and Oncology Progress
- Moderna's Market Cap Surpasses BioNTech by Over Three Times Amid Diverging Biotech Pipelines
- BioNTech Announces Closure of Three Manufacturing Sites in Germany
- BioNTech Faces Colorectal Cancer Vaccine Setback but Reports Lung Cancer Trial Success
- BMO Downgrades BioNTech Stock Amid Clinical Setback in Cancer Vaccine Trial
- Moderna Shares Rise After Melanoma Vaccine Study Selected for Prestigious ESMO Symposium
- BioNTech Terminates Colorectal Cancer Vaccine Trial Amid Efficacy Concerns
- Moderna's Stock Rises on Strong Momentum from Cancer Vaccine Data
- BioNTech's Lung Cancer Drug Shows Promising Survival Results in Phase 3 Trial
- Moderna Surges 8% Amid Momentum Despite Lack of New Catalyst
- BioNTech Shares Drop Following BMO Downgrade, Reduced Price Target
- BioNTech Rallies on Positive mRNA Cancer Trial Results from Competitor
- Arcturus and Moderna Stocks Drop Following BioNTech's Cancer Vaccine Trial Halt
- BioNTech Discontinues Mid-Stage Trial for Colorectal Cancer Vaccine
- BioNTech Shares Drop After Colorectal Cancer Vaccine Trial Fails
- BioNTech Rises Amid Post-Pandemic Biotech Surge but Faces Pressure to Improve Fundamentals
- Moderna Shares Surge on Positive Cancer Vaccine Trial Data
- BioNTech Stock Rally Seen as Temporary by Analysts
- Moderna and Merck's Melanoma Therapy Meets Primary Goal in Phase 3 Trial
- Arbutus Biopharma and Roivant Sciences Sue Over Patents Related to Pfizer-BioNTech's COVID-19 Vaccine
- Cathie Wood's Ark Invest Sells $7.4 Million Worth of BioNTech Stock
- Ark Invest Sells $7.4 Million Worth of BioNTech Shares
- Two Biotech Stocks Considered Potential Buyout Targets
- BioNTech Shifts Strategy Toward Tumor-Centric Oncology with Key Clinical Data
- CureVac Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technology
- Morgan Stanley Raises Price Target for BioNTech SE Amid Positive Clinical Trial Results
- Intuitive Surgical Surpasses Earnings and Revenue Expectations, Tech Sector Faces Sell-Off